Lurie Children’s Hospital added four beds and 20 new staffers to the hospital’s renovated inpatient psychiatric unit as a part of a statewide effort to address a major shortage of mental health care ...

Chicago’s South Side residents now have access to a new sickle-cell treatment clinic at Roseland Community Hospital. On Monday, Roseland held a ribbon-cutting ceremony introducing Dr. Mahoud Mahafzah ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Creating a virtual brain may sound like a science-fiction nightmare, but for neuroscientists in Japan and at Seattle’s Allen Institute, it’s a big step toward a long-held dream. They say their ...

The idea that we’re living inside a simulation, as popularized by “The Matrix” franchise, has piqued the interest of scientists for decades. In 2003, philosopher Nick Bostrom proposed in a highly ...

The true nature of our universe as been an open debate for millennia, and recently, scientists and philosophers have pondered whether it might be a hyper-realistic simulation perpetuated by some super ...

JRPGs Romancing Saga, a Square Enix JRPG released in 1992, remade in 2005, and remastered in 2022, gets yet another re-release: "I had always wanted to make a grand fantasy RPG in the style of The ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

Dead Cells developer Motion Twin has explained why it decided to move on to its co-op roguelite Windblown rather than follow up on its breakout hit. Speaking to PCGamesN, Motion Twin creative director ...

Survival & Crafting Peak devs were ready to go 'into vacation mode' after releasing it, but then it sold 1M copies in the first week: 'That quickly became a pipe dream' Roguelike We're living in the ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.

Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...